• Spearhead global expansion initiatives by analyzing international healthcare environments, identifying key market opportunities, and adapting products to meet local regulatory and clinical standards.• Lead a multidisciplinary team in designing and executing a product strategy focused on expanding Otsuka Pharmaceutical's prescription digital therapeutic, Rejoyn, across international markets, ensuring compliance with various regulatory landscapes.• Oversee cross-functional alignment across scientific, commercial, and engineering teams, managing timelines and facilitating effective collaboration to support global product development, launch, and sustained market success.

• Defined and executed the product strategy for a regulated digital therapeutic targeting opioid use disorder (OUD), aligning clinical and commercial goals to drive impactful health outcomes in partnership with Indivior.• Directed a cross-functional team of 15, including PMs, engineers, designers, and clinicians, establishing efficient communication processes and managing a $1.5M budget to ensure seamless delivery of key milestones.• Oversaw the development of various features such as evidence-based behavior change tools, biospecimen tracking, and cognitive behavioral therapy educational lessons, aimed at enhancing patient engagement and therapeutic effectiveness for OUD.•Directly managed a Senior PM, providing guidance on executing the product roadmap while enhancing their skills in leadership, risk management, and stakeholder communication to elevate team performance.

• Manage a globally distributed team comprising 5 Learning Facilitators (Teaching Assistants) and 4 Assessors (Grading Assistants), overseeing more than 2000 participants across the two programs.• Spearheaded the successful launch of two Artificial Intelligence programs at the MIT Sloan School of Management: "Artificial Intelligence in Healthcare" and "Artificial Intelligence in Pharma and Biotech."

• Led the development and expansion of Fitbit’s Stress Management and Mindfulness features, scaling from 1 to 7 devices and launching industry-first innovations like the continuous EDA sensor on Sense 2, resulting in increased Premium Trial activations and 1.7M MAUs.• Pioneered Fitbit’s Journaling and Logging initiative, driving a comprehensive data-capturing strategy and managing cross-functional teams through feature development, technical migrations, and integration of horizontal logging capabilities.• Co-led the development of Google’s Mental Health Product Strategy across Search, YouTube, and DSPA, securing executive buy-in and aligning key stakeholders to drive long-term vision and OKRs for Google’s Mental Health Center of Excellence.• Oversaw the launch of Fitbit’s Charge 5 EDA sensor, introducing the market’s first EDA sensor on a tracker with over 5 million app sessions, and innovated new mobile-to-device handoff functionality based on user feedback for enhanced usability.

• Directed the product strategy for Verana’s physician-focused applications, including clinical trial tooling, clinical workflow solutions, and data warehousing platforms.• Collaborated with engineering, design, and data science teams to optimize physician app performance and adoption, driving feature improvements based on clinician feedback.

• Partnered with UX research to lead the design and development of Practice Insights, a clinical application that streamlined physician workflows and data insights, increasing usage by 25%.• Established success metrics and aligned features to business objectives, fostering greater clinician satisfaction and efficiency.

• As Insight's Health Domain Lead, I set the vision for all of Insight's Health Data Science programs across the US, facilitated collaboration and knowledge sharing between programs, and established goals and projects aimed at pushing Insight's expertise within the health, biotech, and life sciences industries. • Oversaw the profitability and long-term growth of Insight’s Health Data Science Program in Silicon Valley.• Developed quarterly product plans to identify projects for improved product-market fit, resource allocation, and program deployment. • Built and maintained partnerships with over 160 companies across the health, non-profit, and biotech sectors for partnerships, consulting, and advisory services.• Created and implemented a business development pipeline to generate partner company leads, increase client conversion, and increased tracking opportunities via Salesforce. This new pipeline resulted in increased partner company engagement and has been implemented across all programs. • Oversaw four cohorts of the Health Data Science program from beginning to end, managing outreach, admissions, product management, and placement.• Advised data science fellows on pro-bono consulting projects for over 30 health and biotech startups, focusing on MVP development; data acquisition and analysis; model/algorithm design; testing & validation; and communication of results to stakeholders.• Launched an external tech-talks program to identify and evangelize new health data science methods and technologies, hosting over five events for over 200 people.

• Served as the liaison between Seven Bridges and its clients to: understand technical requirements; determine product specifications and roadmap; and ensure successful product development, implementation, and evaluation. • Led an international team of six (three bioinformaticians, two SWE, one designer) to build four analytics platforms and five bioinformatics pipelines for five biotech and pharmaceutical companies.• Led my team through three moderate pivots, involving strategy refinement and shifting team to new vision on a fully customized cloud-based biomedical platform for a Fortune 500 client. • Led the product development of white-labeled platforms for three cloud-provider clients in China.• Served as a Seven Bridges representative in the Blood Profiling Atlas in Cancer (BloodPAC), and successfully oversaw the project that led to the adoption of 13 pre-analytical standards for liquid biopsy technologies by the U.S. F.D.A.

• Identified conditions supporting high West Nile prevalence in Los Angeles, CA, using random forest models in R and maximum entropy modeling. • Developed a hazard vulnerability assessment model to identify infectious disease risk under current and future climate projections for the Acute Communicable Disease Program.• Interviewed 30 key public health specialists and identified three levels of industry barriers and provided recommendations towards using geospatial modeling methods to improve West Nile Virus surveillance and mitigation programs.• Contributed to the development and communication of a joint UCLA - LACDPH collaboration to create a 16-part “Climate and Health” series for public health practitioners, resulting in an increased knowledge of public health practitioners surrounding the impacts of climate change and public health.

• Oversaw the allocation and distribution of a $1MM Kresge Foundation grant to 13 local public health departments across the United States on the topic of climate change, equity, and public health. • Consulted with the 13 public health agencies in project scoping, planning, and implementation, and established evaluation criteria for the range of projects which included: vector-borne disease abatement programs, extreme heat emergency plans, enhanced water catchment systems, and improvements in climate literacy among interfaith communities. • Aided in the identification and recruitment of organizations to the U.S. Climate and Health Alliance, a national network of health and public health practitioners dedicated to addressing the impacts of climate change on health.

• Served as the primary epidemiologist for 5 food-borne outbreak investigations and provided recommendations for increased food-handling practices.• Conducted signal detection surveillance, outbreak investigation/response (collaborating with local, state, federal agencies), data analysis, and report writing.• Managed new intern training and designed a protocol to standardize data collection, improve data integrity and data cleaning to ensure more rapid outbreak detection.• Analyzed patient outcomes and healthcare data to develop community infectious disease interventions and educational programs to optimize future program development.

• Developed baseline healthcare surveys to assess the risk of dengue fever due to climate change for a Rockerfeller Foundation funded project. • Managed a team of 25 high-performing field workers and nurses that conducted over 6,000 surveys within six months.• Analyzed large amounts of healthcare data using R and SAS to identify risk priorities and developed educational materials and health contingency plans, resulting in a 33% increase in community-level risk reduction behavior in project locations over six months.• Produced key recommendations for clients, which included the Indonesian Red Cross, Columbia University, the Fashion Institute of Technology, and board members of the Red Cross and Red Crescent Climate Center.

• Assisted in an EPI-Aid with the Epidemic Intelligence Service to assess the respiratory health risk associated with the 2008 Midwestern floods.• Analyzed large amounts of healthcare data to identify heatstroke mortality for the CDC/NASA ROSES Project on extreme heat vulnerabilities in the Northeast United States.• Co-authored a chapter with the World Bank on the “Health Impacts of Climate Change in South Asia” • Communicated EPI-AID findings to the Director of the National Center for Environmental Health, Dr. Howard Frumkin.